Iodine (131 I) derlotuximab biotin is a chimeric monoclonal antibody that targets DNA-histone H1 complex. Iodine (131 I) derlotuximab biotin is designed for the treatment of recurrent glioblastoma multiforme.
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.